Colin Terence Dollery

Colin Terence Dollery's AcademicInfluence.com Rankings

Philosophy

#2688

World Rank

#4512

Historical Rank

Logic

#717

World Rank

#1233

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Colin Terence Dollery Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Colin Terence Dollery's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension (1997) (2671)
DISTRIBUTION OF BLOOD FLOW IN ISOLATED LUNG; RELATION TO VASCULAR AND ALVEOLAR PRESSURES. (1964) (1013)
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects (1991) (457)
Distribution of blood flow and ventilation-perfusion ratio in the lung, measured with radioactive CO2 (1960) (431)
Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. (1980) (411)
HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY (1980) (366)
Serum-insulin in essential hypertension and in peripheral vascular disease. (1966) (342)
Absorption and metabolism of nicotine from cigarettes. (1975) (322)
URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITIS (1989) (320)
Prostacyclin is not a circulating hormone in man. (1982) (291)
The Retinal Circulation (1972) (273)
Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidine (1977) (267)
The 3D OrbiSIMS—label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power (2017) (242)
GLUCOSE INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS; A FOURTEEN-YEAR FOLLOW-UP (1982) (239)
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels (2008) (220)
Change in symptoms of hypertensive patients after referral to hospital clinic. (1976) (218)
The clinical pharmacology of beta-adrenoceptor-blocking drugs. (1976) (212)
Resistance to β‐adrenoceptor stimulants (a possible explanation for the rise in asthma deaths) (1971) (199)
GLUCOSE INTOLERANCE DURING DIURETIC THERAPY Results of Trial by the European Working Party on Hypertension in the Elderly (1978) (194)
Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire (1973) (190)
INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPA (1966) (185)
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. (1980) (179)
Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma (1980) (171)
Drug concentration in saliva (1978) (163)
Increased Pulmonary Vascular Resistance in the Dependent Zone of the Isolated Dog Lung Caused by Perivascular Edema (1965) (161)
DETERIORATION OF GLUCOSE TOLERANCE IN HYPERTENSIVE PATIENTS ON PROLONGED DIURETIC TREATMENT (1976) (156)
Regional Uptake of Radioactive Oxygen, Carbon Monoxide and Carbon Dioxide in the Lungs of Patients with Mitral Stenosis (1960) (143)
The Concise Guide to Pharmacology 2013/14: Overview (2013) (143)
Circulating catecholamines in exercise and hyperventilation induced asthma. (1981) (137)
CLONIDINE WITHDRAWAL IN HYPERTENSION Changes in Blood-pressure and Plasma and Urinary Noradrenaline (1977) (136)
Metabolism of isoprenaline in dog and man (1972) (135)
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. (1975) (133)
Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. (1969) (132)
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. (1975) (131)
Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. (1984) (131)
Interaction between Clonidine and Desipramine in Man (1973) (128)
Leukotriene C4 elimination and metabolism in man. (1990) (128)
Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. (1974) (127)
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex (1986) (121)
Studies of the Retinal Circulation with Fluorescein* (1962) (121)
Drug-induced diabetes. (1962) (121)
Methyldopa in hypertension. Clinical and pharmacological studies. (1962) (121)
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. (1989) (120)
Streptokinase in central retinal vein occlusion: a controlled clinical trial. (1976) (120)
Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique; limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. (1981) (119)
CIRCULATING PROSTACYCLIN MAY BE REDUCED IN DIABETES (1979) (117)
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. (1986) (117)
alpha 1-Adrenergic receptors in guinea pig myocardium: identification by binding of a new radioligand, (3H)-prazosin. (1979) (114)
Isoprenaline resistance and the use of pressurised aerosols in asthma. (1968) (111)
Single-Cell Analysis: Visualizing Pharmaceutical and Metabolite Uptake in Cells with Label-Free 3D Mass Spectrometry Imaging. (2015) (110)
Distribution of blood flow and ventilation-perfusion ratio in the lung, measured with radioactive carbon dioxide. (1960) (108)
INCREASED SENSITIVITY AND ACCURACY OF PHAEOCHROMOCYTOMA DIAGNOSIS ACHIEVED BY USE OF PLASMA-ADRENALINE ESTIMATIONS AND A PENTOLINIUM-SUPPRESSION TEST (1981) (108)
Intravenously administered isoproterenol sulfate dose-response curves in man. (1972) (107)
Experimental retinal branch vein occlusion. (1970) (107)
Comparison of Cardiorespiratory Effects of Isoprenaline and Salbutamol in Patients with Bronchial Asthma (1970) (104)
MINOXIDIL IN RESISTANT HYPERTENSION (1977) (101)
RELEASE OF PROSTACYCLIN IN VIVO AND ITS ROLE IN MAN (1983) (101)
CONCENTRATION OF (±)‐PROPRANOLOL IN ISOLATED, PERFUSED LUNGS OF RAT (1976) (100)
Clinical and pharmacological studies with guanethidine in the treatment of hypertension. (1960) (99)
Distribution of blood flow and the pressure-flow relations of the whole lung (1965) (98)
Chronic heart failure in the guinea pig increases cardiac α1- and β-adrenoceptors (1980) (97)
Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. (1989) (97)
Effect of raised intraocular pressure on the retinal and choroidal circulation. (1968) (91)
Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit. (1974) (91)
Role of nifedipine in treatment of hypertension. (1983) (90)
A symptom questionnaire for hypertensive patients. (1974) (90)
Circadian rhythm of baroreflex reactivity and adrenergic vascular response. (1980) (90)
Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. (1993) (89)
Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. (1977) (88)
Risk predictors, risk indicators, and benefit factors in hypertension. (1987) (85)
Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. (1984) (84)
Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. (1994) (84)
Uptake of oxygen-15-labeled CO2 compared with carbon-11-labeled CO2 in the lung. (1962) (81)
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. (1966) (81)
Estimation of retinal blood flow by measurement of the mean circulation time. (1971) (80)
Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. (1989) (78)
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. (1979) (78)
Intracellular Drug Concentrations (2013) (78)
Effect of changes in intraocular pressure on the retinal microcirculation. (1974) (77)
Glucose tolerance in hypertensive patients on long-term diuretic therapy. (1967) (75)
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit (1973) (74)
Environmental factors affecting paracetamol metabolism in London factory and office workers. (1980) (73)
Human lung adrenoreceptors studied by radioligand binding. (1980) (72)
Effect of propranolol in mild hypertension. (1966) (71)
The pharmacodynamics and metabolism of propranolol in man (1970) (71)
Elevated plasma 6‐keto‐prostaglandin F1α in patients in septic shock (1985) (71)
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. (1967) (71)
Arterial Fluorescein Studies in Diabetic Retinopathy (1967) (70)
Effect of vasoactive peptides on prostacyclin synthesis in man (1986) (69)
Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project (1995) (68)
The response of normal retinal blood vessels to angiotensin and noradrenaline (1963) (68)
Influence of Hospitalization and Placebo Therapy on Blood Pressure and Sympathetic Function in Essential Hypertension (1981) (66)
DIFFERENCES IN THE METABOLISM OF DRUGS DEPENDING UPON THEIR ROUTES OF ADMINISTRATION * (1971) (66)
A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals. (1980) (66)
PRODUCTION OF 6-OXO-PGF1α BY HUMAN LUNG IN VIVO (1979) (65)
Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. (1986) (64)
Prostaglandin D2 and histamine release in cold urticaria. (1986) (63)
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. (1979) (62)
Effects of intravenous infusions of prostaglandin D2 in man. (1984) (62)
Demonstration of α1-adrenoceptors in guinea pig lung using 3H-prazosin (1979) (62)
Thromboxane A2 biosynthesis in acute asthma and after antigen challenge. (1991) (61)
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. (1970) (61)
Increased production of cysteinyl leukotrienes in hepatorenal syndrome. (1990) (60)
A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. (1981) (59)
The Challenge of Complexity (2010) (59)
Clinical pharmacology and potential of prostacyclin. (1983) (58)
Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. (1981) (58)
Bretylium tosylate in the treatment of hypertension. (1960) (57)
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man (1980) (56)
RISK FACTORS FOR DEATH IN TREATED HYPERTENSIVE PATIENTS Report from the D.H.S.S. Hypertension Care Computing Project (1979) (56)
Circadian variation in adrenergic responses in asthmatic subjects. (1982) (56)
The Distribution of Blood and Gas within the Lungs Measured by Scanning after Administration of 133Xe (1963) (56)
Effect of enalapril on the skin response to bradykinin in man. (1987) (55)
Assessment of selective β‐adrenoceptor blockade in man (1973) (55)
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure. (1988) (54)
The mode of action of chlorothiazide in hypertension: with special reference to potentiation of ganglion-blocking agents. (1959) (54)
Introduction to Science (1969) (54)
Endothelin‐induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat (1989) (52)
Effect of diuretic therapy on glucose tolerance in hypertensive patients. (1971) (52)
Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 in biological fluids (1982) (51)
Clinical pharmacology – the first 75 years and a view of the future (2006) (51)
Cotton-wool Spots in Diabetic Retinopathy (1969) (51)
Measurement of plasma histamine in asthma (1983) (50)
Metabolism of nicotine by the isolated perfused dog lung. (1975) (50)
RETINAL SOFT EXUDATESA Clinical Study be Colour and Fluorescence Photograghy (1964) (50)
The Rate of Formation and Disappearance of Microaneurysms in Diabetic Retinopathy * (1970) (50)
Labetalol in resistant hypertension. (1976) (50)
Interpretation of radioactive gas clearance rates in the lung. (1962) (50)
Quantitative analysis of prostanoids in biological fluids by combined capillary column gas chromatography negative ion chemical ionization mass spectrometry. (1984) (49)
Repair of anomalous pulmonary venous connection to the superior vena cava. (1995) (49)
The use of radioactive carbon dioxide to measure regional blood flow in the lungs of patients with pulmonary disease. (1961) (48)
Hyperuricaemia Related to Treatment of Hypertension (1960) (48)
Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients (1980) (47)
Randomised controlled trial of computer-held medical records in hypertensive patients. (1976) (47)
Drug treatment of heart failure. (1985) (47)
Use of Radioactive Xenon for Studies of Regional Lung Function* (1962) (46)
Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Control of vascular reactivity by endogenous prostanoids. (1986) (46)
Hydralazine, antinuclear antibodies, and the lupus syndrome. (1982) (45)
Environmental factors affecting antipyrine metabolism in London factory and office workers. (1979) (45)
Atenolol in essential hypertension (1976) (45)
Metabolism of terbutaline in man and dog. (1974) (44)
HIGH OXYGEN PRESSURE AND THE RETINAL BLOOD-VESSELS. (1964) (44)
Sedative and cardiovascular effects of clonidine and nitrazepam (1980) (44)
Monitoring adverse reactions to drugs. (1977) (44)
Lapatinib‐Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes (2012) (43)
Changes in blood pressure, heart rate, and plasma noradrenaline concentration after sudden withdrawal of propranolol. (1979) (43)
Incidence of a positive direct coombs test in patients on alpha-methyldopa. (1966) (43)
Fluorescein Studies of Diabetic Retinopath* (1964) (43)
Inhaled prazosin in asthma. (1981) (43)
Absorption of nicotine from small cigars (1978) (43)
A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. (1976) (42)
RETINAL SOFT EXUDATES. A CLINICAL STUDY BY COLOUR AND FLUORESCENCE PHOTOGRAPHY. (1964) (41)
Apparent resistance to hypotensive effect of clonidine. (1977) (41)
DIABETOGENIC ACTION OF BENZOTHIADIAZINES: SERUM-INSULIN-LIKE ACTIVITY IN DIABETES WORSENED OR PRECIPITATED BY THIAZIDE DIURETICS. (1963) (41)
Environmental effects on antipyrine half‐life in man (1977) (41)
Methyldopa in hypertension. (1963) (41)
REGIONAL PULMONARY BLOOD FLOW IN PATIENTS WITH CIRCULATORY SHUNTS (1961) (39)
Beyond genomics (2007) (39)
Central hypotensive effect of propranolol in the rabbit. (1973) (39)
HÆMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES (1963) (39)
Fluorescein angiography of the fundus in diabetic retinopathy. (1970) (38)
Regulation of norepinephrine release by peripheral α2‐receptor stimulation (1981) (38)
Regional variations in uptake of radioactive CO in the normal lung. (1960) (38)
Elimination kinetics of amobarbital in mothers and their newborn infants (1973) (38)
DIURETIC AND HYPOTENSIVE PROPERTIES OF ETHACRYNIC ACID: A COMPARISON WITH HYDROCHLOROTHIAZIDE. (1964) (38)
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. (2011) (38)
Amiloride hydrochloride in hypertensive patients. (1968) (38)
Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion. (1984) (37)
Contribution of environmental factors to variability in human drug metabolism. (1979) (37)
Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension (1977) (36)
The importance of central adrenergic neurones in renal hypertension in rabbits (1974) (36)
Changes in Blood Pressure and Plasma Catecholamines Caused by Tyramine and Cold Exposure (1984) (36)
Glucose Tolerance During Antihypertensive Therapy in Patients with Diabetes Mellitus (1985) (36)
Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. (1991) (36)
The metabolism of sympathomimetic bronchodilator drugs by the isolated perfused dog lung. (1973) (36)
Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia. (1973) (35)
Psychological features of patients with hypertension attending hospital follow-up clinics (1976) (35)
Sedative and cardiovascular effects of clonidine and nitrazepam. (1981) (35)
Adrenaline and hypertension. (1984) (33)
A Comparison of the Pulmonary Blood Flow between Left and Right Lungs in Normal Subjects and Patients with Congenital Heart Disease (1961) (33)
Value of routine electrocardiography in hypertensive patients. (1972) (33)
INCREASED VASCULAR RESISTANCE IN THE LOWER ZONE OF THE LUNG CAUSED BY PERIVASCULAR OEDEMA. (1964) (33)
Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. (1989) (33)
Total profiling by GC/NICIMS of the major cyclo-oxygenase products from antigen and leukotriene-challenged guinea-pig lung. (1984) (32)
Clonidine and sympathetic activity during sleep. (1979) (32)
Intravenous urography and renal function. (1968) (32)
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. (1980) (32)
Dynamic aspects of the retinal microcirculation. (1968) (32)
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. (1970) (32)
Methyldopa and haemolytic anaemia. (1966) (31)
Enzyme induction. (1972) (31)
Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake (2004) (31)
Atenolol and chlorthalidone in combination for hypertension. (1979) (31)
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. (1980) (31)
The biochemical diagnosis, localization and follow up of phaeochromocytoma: the role of plasma and urinary catecholamine measurements. (1980) (31)
Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin. (1980) (30)
Hypertension in the young. (1967) (30)
The Future Is Much Closer Collaboration Between the Pharmaceutical Industry and Academic Medical Centers (2010) (29)
The Medical Research Council Hypertension Trial: the smoking patient. (1988) (29)
Experimental retinal branch vein occlusion in rhesus monkeys. II. Retinal blood flow studies. (1979) (29)
Does it matter how blood pressure is reduced? (1981) (29)
Assimilation of D and L I-C-14 Glucose into the Retina, Brain and Other Tissues (1971) (28)
Distribution of gas and blood in the lungs in disease. (1963) (28)
Urinary leukotriene E4 levels in patients with atopic dermatitis (1997) (28)
The influence of the route of administration on urinary metabolites of isoetharine. (1974) (28)
Concentration effect relationships of infused histamine in normal volunteers (1982) (28)
Centrally acting drugs in antihypertensive therapy. (1980) (28)
Dose and concentration-effect relations for rilmenidine. (1988) (27)
Optimal Blood Pressure Control in Treated Hypertensive Patients: Report from the Department of Health Hypertension Care Computing Project (DHCCP) (1994) (27)
Cancer mortality and atenolol treatment. (1993) (27)
High-resolution sub-cellular imaging by correlative NanoSIMS and electron microscopy of amiodarone internalisation by lung macrophages as evidence for drug-induced phospholipidosis. (2017) (27)
Efficacy of nifedipine as a step 3 antihypertensive drug. (1983) (27)
Pulmonary platelet kinetics in asthma. (1985) (26)
ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION. (1964) (26)
Malignant Hypertension and Hypokalaemia: Cured by Nephrectomy (1959) (26)
Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women. (2013) (26)
BLOOD CAN SYNTHESISE PROSTACYCLIN (1983) (25)
Pharmacokinetics of indoramin in man. (1976) (25)
The marginal plasma zone in the retinal microcirculation. (1970) (24)
Pharmacological basis for combination therapy of hypertension. (1977) (24)
The effect of dopamine on renal blood flow in man (1971) (24)
Risk factors for ischaemic heart disease and stroke mortality in young and old hypertensive patients. (1995) (24)
Prostacyclin binding to guinea pig pulmonary receptors. (1981) (23)
Monitoring liver safety in drug development: the GSK experience. (2007) (23)
Comparison of black and white patients attending hypertension clinics in England. (1979) (23)
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. (1984) (23)
Importance of central catecholaminergic neurones in the development and maintenance of renal hypertension. (1973) (23)
Thromboxane and prostacyclin in disease: a review. (1983) (22)
Advantages and disadvantages of alpha 2-adrenoceptor agonists for systemic hypertension. (1988) (22)
Hypertensive Retinopathy: Caliber Changes in Retinal Blood Vessels Following Blood‐Pressure Reduction and Inhalation of Oxygen (1968) (22)
Computer-based Hypertension Clinic Records: A Co-operative Study (1974) (22)
Oral nafazatrom in man: effect on inhaled antigen challenge. (1987) (22)
The metabolic fate of DL(7-3H)isoprenaline in man and dog. (1969) (22)
Plasma catecholamine and cardiovascular responses to morphine and D-ala2-d-leu5-enkephalin in conscious rats. (1983) (22)
No evidence for involvement of endogenous opioid peptides in effects of clonidine on blood pressure, heart rate and plasma norepinephrine in anesthetized rats. (1984) (22)
Effect of Pituitary Ablation on Diabetic Retinopathy Studied by Fluorescence Angiography (1970) (22)
Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension. (1980) (22)
Chronic heart failure in the guinea pig increases cardiac alpha 1- and beta-adrenoceptors. (1980) (21)
Intracellular Drug Uptake-A Comparison of Single Cell Measurements Using ToF-SIMS Imaging and Quantification from Cell Populations with LC/MS/MS. (2017) (21)
Coca Chewing and High-Altitude Stress: A Spurious Correlation [and Comments and Reply] (1983) (20)
Reversal of Retinal Vascular Changes in Diabetes (1965) (20)
Absorption of Inhaled Radioactive Water Vapour (1961) (20)
INTERPRETATION OF 133XE LUNG WASH-IN AND WASH-OUT CURVES USING AND ANALOGUE COMPUTER. (1965) (19)
Plasma histamine concentration during propranolol induced bronchoconstriction. (1985) (19)
Single-step procedure for the extraction and purification of leukotrienes B4, C4 and D4. (1987) (19)
Metabolism of propranolol in rat: the fate of the N-isopropyl group. (1973) (19)
Clinical pharmacology of calcium antagonists. (1991) (18)
Effects of histamine type 2 receptor stimulation on myocardial function in normal subjects. (1982) (18)
Central bronchogenic cyst: treatment by extrapleural percutaneous aspiration. (1989) (18)
FLUORESCEIN STUDIES OF THE RETINAL CIRCULATION IN DIABETICS*† (1963) (18)
Pharmacokinetics of dextro-, leavo- and racemic propranolol in man (1972) (18)
Surgical Treatment of Emphysema (1966) (18)
Streptokinase in the treatment of central retinal vein occlusion. A controlled trial. (1974) (18)
Assessment of MK‐912, an α2‐adrenoceptor antagonist, with use of intravenous clonidine (1989) (17)
Haemodynamic effects of guanethidine. (1961) (17)
Arterial Fluorescein Studies in Diabetic Retinopathy (1965) (17)
Studies by fluorescence photography of papilloedema in malignant hypertension1 (1965) (17)
Antipyrene clearance in Indian villagers. (1980) (17)
Free and total 3-methoxy-4-hydroxyphenylethylene glycol in human cerebrospinal fluid: relationship to blood pressure in hypertensives and patients with neuropsychiatric disease. (1977) (16)
The contribution of psychological features to the symptoms of treated hypertensive patients (1977) (16)
Campylobacter pylori, duodenal ulcer disease, and gastrin. (1989) (16)
Reduction of circulating 25-hydroxyvitamin D by antipyrine. (1979) (16)
Generation of hydroxyeicosatetraenoic acids by human inflammatory cells: analysis by thermospray liquid chromatography-mass spectrometry. (1986) (16)
The relationship between blood flow and clearance rate of radioactive carbon dioxide and oxygen in normal and oedematous lungs (1962) (16)
A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand. (1985) (16)
Estimation of sympathetic activity in essential hypertension (1982) (16)
Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. (1985) (16)
Histamine released locally after intradermal antigen challenge in man. (1984) (15)
Acute effects of varying doses of propranolol upon oxygen haemoglobin affinity in man. (1974) (15)
Eye symptoms in patients taking propranolol and other hypotensive agents. (1977) (14)
Compliance with anticonvulsant therapy in a hospital clinic and in the community. (1978) (14)
Role of nifedipine in the treatment of resistant hypertension. Comparison with hydralazine in hospital outpatients. (1984) (14)
Prostacyclin in the circulation of patients with vascular disorders undergoing surgery. (1986) (14)
Large-dose urography. Is there an optimum dose? (1967) (14)
Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine. (1975) (14)
Central noradrenergic mechanisms and the cardiovascular effects of intracerebroventricular (+)- and (−)-propranolol in the conscious rabbit (1975) (14)
Norepinephrine release in essential hypertension (1981) (14)
Community care compared with hospital outpatient care for hypertensive patients. (1982) (14)
Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy. (1976) (14)
Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy (1976) (13)
Assessment of selective beta-adrenoceptor blockade in man. (1973) (13)
Life threatening thrombocytopenia in sarcoidosis. (1990) (13)
Physiological and Pharmacological Interactions of Antihypertensive Drugs (1965) (13)
Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors (1977) (12)
Pathophysiology of the Retinal Vascular Bed Following Acute Embolization (1966) (12)
Quantitative analysis of arachidonic acid metabolites in complex biological fluids using capillary gas chromatography/negative ion chemical ionisation mass spectrometry (1983) (12)
Retinal microemboli: cine fluorescence angiography. (1965) (12)
The future of clinical pharmacology in the UK (2006) (12)
The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects. (1985) (12)
Bradykinin Induced Bronchoconstriction in Man (1985) (12)
Central and peripheral catecholamine mechanisms in circulatory control. (1976) (11)
Clinical Trials of New Drugs (1977) (11)
Plasma concentration of α-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester (1975) (11)
Action of chlorothiazide on the distribution excretion and hypotensive effect of pempidine in man. (1961) (11)
Regional Lung Function in Kyphoscoliosis 1 (1965) (11)
Value of fluid deprivation in large-dose urography. (1968) (11)
Methyldopa in the treatment of hypertension. (1965) (11)
Is low salt dietary advice a useful therapy in hypertensive patients with poorly controlled blood pressure? (1984) (11)
Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester. (1984) (11)
Drugs and Sensory Functions. (1968) (10)
Predominance of locally-produced prostaglandin E2 over prostacyclin in skin incisions in man. (1987) (10)
Relation between treated blood pressure and death from ischaemic heart disease at different ages: a report from the Department of Health Hypertension Care Computing Project (1992) (10)
Pharmacology of M & B 17803A in man and dog. (1971) (10)
Acquired resistance to beta stimulants: a possible explantion for the rise in the asthma death rate in Britain. (1973) (10)
Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide. (1978) (10)
A fluorescent analogue of propranolol does not label beta adrenoceptor sites (1980) (10)
Retinal photography using fluorescein. (1963) (10)
Elevated plasma 6-keto-prostaglandin F1 alpha in patients in septic shock. (1985) (9)
The effects of platelet aggregates on the retinal microcirculation. (1967) (9)
Propranolol--ten years from introduction. (1974) (9)
Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidine. (1991) (9)
Retinal vascular changes following exposure to high-intensity light. (1967) (9)
Central hypotensive effect of propranolol. (1976) (9)
Effects of papaverine on the retinal microcirculation. (1973) (9)
Action of 3-isobutyl-1-methylxanthine and prostaglandins D2 and E1 on histamine release from rat and guinea pig mast cells. (1983) (9)
The effects of long term administration of dopamine on renal function in hypertensive patients (1973) (9)
Letter: Clonidine overdose. (1975) (9)
Central nervous system mechanisms in blood pressure control (2004) (9)
Semiempirical Rules To Determine Drug Sensitivity and Ionization Efficiency in Secondary Ion Mass Spectrometry Using a Model Tissue Sample. (2016) (9)
Hypertension trial results: consensus and conflicts. (1995) (9)
Initial care of hypertensive patients. Influence of different types of clinical records. (1977) (9)
Myocardial Necrosis (1963) (8)
Therapeutic opportunities in vasoocclusive disease. (1986) (8)
Use of Tyramine to Probe Pulmonary Noradrenaline Release in Asthma (1983) (8)
Collateral blood flow after branch arteriolar occlusion in the human retina. (1967) (8)
Alveolar gas concentrations of fluorocarbons-11 and -12 in man after use of pressurized aerosols (1974) (8)
Use of 18F labelled fluorocarbon-11 to investigate the fate of inhaled fluorocarbons in man and in the rat (1974) (8)
Diurnal changes in plasma volume in hypertensive patients: effect of posture and sodium depletion. (1968) (8)
An Approach to Computer Processing of Clinical Data (1976) (8)
CALIBRE CHANGES IN RETINAL ARTERIOLES. (1963) (8)
Calcium antagonists and histamine secretion from rat peritoneal mast cells (1983) (7)
Reduction of beta-blocking drugs in hypertensive patients treated with minoxidil. (1979) (7)
A Novel Hybrid Dual Analyzer SIMS Instrument for Improved Surface and 3D-Analysis (2016) (7)
Lidocaine in the Treatment of Ventricular Arrhythmias (1971) (7)
The effect of noradrenaline infusion on blood pressure and plasma noradrenaline following clonidine administration in man [proceedings]. (1977) (7)
LYMPHOCYTOTOXIC ANTIBODIES IN HYDRALAZINE-INDUCED LUPUS ERYTHEMATOSUS (1979) (7)
The effects of two centrally-acting anti-hypertensive drugs on the quality of life (2004) (7)
Action of Diazoxide (1962) (7)
Duration of effect of single daily dose methyldopa therapy. (1982) (7)
What is the nephrogram? (1967) (7)
Dose-Response in Hypertension (1977) (7)
Sniffing syndrome. (1971) (6)
The top 50 drugs in the UK and Japan: why are they so different? (1994) (6)
The conduct of initial drug studies in man. (1970) (6)
Pharmacological and metabolic studies with propranolol in man. (1970) (6)
Adrenergic drugs in the treatment of hypertension. (1973) (6)
Effects of intrarenal infusions of bradykinin and acetylcholine on renal blood flow in man. (1965) (6)
Location of vascular alpha 2-adrenoceptors in man. (1984) (6)
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity (2004) (6)
Routine intravenous urography in the investigation of hypertension. (1976) (6)
A crossover comparison of clonidine and methyldopa in hypertension (1972) (6)
The Effect of Clonidine on Biochemical Indices of Sympathetic Function in Normotensive Subjects (1976) (6)
Des-Amino-D-Arginine Vasopressin Does Not Increase Circulating Levels of Prostacyclin or Thromboxane A2 During Infusion in Man (1983) (6)
Is prostacyclin a circulating anti-coagulant? (1978) (6)
Velocity profiles in the retinal microcirculation. (1973) (6)
Urinary N tau-methylimidazole acetic acid excretion in respiratory disease. (1990) (6)
Lost in Translation (LiT) (2014) (6)
The use of bretylium tosylate (Darenthin) in hypertension. (1961) (5)
Studies on the pharmacology of central opioid-induced increases in plasma catecholamines in conscious rats (1984) (5)
Fifteen year survival of patients presenting with hypertension to a hospital clinic. (1986) (5)
On Coca Chewing and High-Altitude Stress (1983) (5)
Central and peripheral mechanisms in the maintenance of experimental hypertension in the rabbit. (1973) (5)
The importance of bradykinin and histamine in the skin response to antigen. (1988) (5)
Plasma Pempidine Concentrations in Hypertensives (1960) (5)
Retinal vascular alterations in hypertension (1966) (5)
Medical registrar training (1991) (5)
Biochemical indices of sympathetic function in man (1979) (5)
Evaluation of the Symptoms of Treated Hypertensive Patients (1979) (5)
Importance of beta 2-adrenoceptor stimulation in the suppression of intradermal antigen challenge by adrenaline. (1989) (5)
DIAGNOSIS OF SMALL PHÆOCHROMOCYTOMAS (1980) (5)
STUDIES IN FLUORESCENCE RETINAL PHOTOGRAPHY. (1963) (5)
A comparison of propranolol and compound RO3-4787 in the treatment of arterial hypertension in man. (1975) (5)
Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects. (1982) (5)
Letter: Computer-held medical records. (1976) (5)
Blood can synthesize prostacyclin. (1983) (5)
PLASMA-CATECHOLAMINES IN PHÆOCHEROMOCYTOMA (1976) (5)
Pharmacokinetic and pharmacological studies with clonidine in normal subjects. (1976) (5)
The identity of IgE receptors (FcεRII) that mediate cellular activation of human macrophages : evidence against a role for CD23 (1992) (5)
Bronchial reactivity is not increased after inhalation of leukotriene B 4 and prostaglandin D 2 (1988) (5)
Contribution of the liver to overall elimination of propranolol (1976) (5)
Pharmacological effects of drugs on the pulmonary circulation in man (1966) (5)
Demonstration of alpha 1-adrenoceptors in guinea pig lung using 3H-prazosin. (1979) (5)
No evidence for antagonism of clonidine by naloxone in man [proceedings]. (1980) (5)
The effects of amiflamine, a reversible MAO-A inhibitor, on the first pass metabolism of tyramine in dog intestine. (1986) (4)
Adrenergic blockade in hypertension. (1972) (4)
Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats [proceedings]. (1980) (4)
Metabolism of 3H-arachidonic acid in male dog lung in vitro using a perfusion system designed to mimic physiological conditions. (1980) (4)
HYPERTENSIVE RETINOPATHY STUDIED WITH FLUORESCEIN. (1963) (4)
The effects of pentolinium on sympathetic activity in hypertensives and normotensive controls. (1983) (4)
Risk Predictors, Risk Indicators, and Benefit Factors in Hypertension (1987) (4)
The simultaneous analysis of prostanoids in biological fluids by combined capillary column gas chromatography and negative-ion chemical-ionization mass spectrometry (1982) (4)
Clinical evaluation of indoramin, a new antihypertensive agent (1973) (4)
Human lung adrenoceptors identified by radioligand binding [proceedings]. (1980) (4)
The effects of oxygen on retinal circulation. (1969) (4)
Combined action of methyldopa and bethanidine. Evidence for a synergistic effect. (1966) (4)
Gastrinoma syndrome in multiple endocrine neoplasia. (1990) (4)
Medicine and the Pharmacological Revolution (1994) (4)
6 – THE RETINAL MICROCIRCULATION IN SHOCK (1968) (4)
Circulatory changes following retinal embolism by glass microspheres. (1967) (4)
The scientific contribution of clinical pharmacology (2008) (4)
Actions of Chlorothiazide in Hypertension (1960) (4)
Absorption of nicotine by man during cigar smoking [proceedings]. (1977) (4)
THE COOMBS TEST AND METHYLDOPA (1968) (4)
Synopsis of Cardiology (1964) (4)
Prostacyclin concentrations in cord blood and in the newborn. (1985) (4)
Experimental retinal vein occlusion in the rhesus monkey. Radioactive microsphere and radioautographic studies [proceedings]. (1976) (3)
Post-marketing drug surveillance (1981) (3)
Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 alpha in biological fluids. (1982) (3)
Computer-based records in the clinic (a) (1973) (3)
Concentration-effect relationships with FM 24: a new long acting beta-adrenergic receptor antagonist. (1983) (3)
Histamine, Substance P and Neurogenic Flare in Human Skin (1985) (3)
Non-Invasive Measurement of Renal Blood Flow with TC-99M DTPA (1987) (3)
Proceedings: Mechanism of the early pressor effect of centrally administered propranolol in the conscious rabbit. (1974) (3)
Propanolol in Hypertension (1970) (3)
Fifteen-year survival of patients beginning treatment with methyldopa between 1962 and 1966. (1984) (3)
Effects of Acetylcholine on Regional Pulmonary Blood Flow in Patients with Mitral Stenosis (1968) (3)
Changes in sleep pattern, blood pressure, heart rate and plasma noradrenaline after night-time administration of slow release clonidine [proceedings]. (1977) (3)
Distribution of hippuran labelled with 131-I in the kidneys and liver. (1962) (3)
The effect of selective cardiac adrenergicβ-blockade on the hypotensive effect of hydrallazine (1971) (3)
The formation of collaterals. (1968) (3)
Session I. Nervous Anatomy and Physiology of Cardiovascular Control and Orthostatic Regulation (1976) (3)
Plasma-catecholamines in phaeochromocytoma. (1976) (3)
Beta-blocker withdrawal syndrome. (1979) (3)
Diuretic agents and beta-blockers in the treatment of hypertension. (1989) (3)
Proceedings: Doppler blood velocity studies in patients with unstable aortic regurgitation. (1974) (3)
Beta-adrenoceptor blockade: past, present, and future. (1988) (3)
Site of action of methyldopa in lowering the blood pressure in man. (1978) (3)
Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man (2004) (3)
Routes of Administration and Drug Response (1975) (3)
Cause and treatment of atherosclerosis (1982) (3)
Factors Affecting the Care of Patients with Malignant Hypertension (1979) (3)
Raising Blood Pressure (1967) (3)
The quantitative analysis of 6-keto PGF1 alpha in biological fluids by stable isotope dilution utilizing gas chromatography-mass spectrometry (GC-MS) [proceedings]. (1980) (3)
An update on the Medical Research Council Hypertension Trial. (1987) (2)
Session IV. Therapy of Orthostatic Disturbances (1976) (2)
1399 – INTERINDIVIDUAL VARIATION IN NORADRENALINE KINETICS (1978) (2)
Extraction and Release of Noradrenaline and Adrenaline by Human Tissues (1979) (2)
Proceedings: The cardiovascular effects of dobutamine, a selective inotropic catecholamine. (1974) (2)
Mortality in patients who have their antihypertensive therapy changed. (1989) (2)
Hepatic clearance of propranolol in dogs. (1973) (2)
Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade (1979) (2)
Long-term anticoagulant treatment after myocardial infarction. (1970) (2)
The place of bretylium tosylate in the treatment of high blood pressure. (1960) (2)
Proceedings: Regional brain concentration of propranolol and its hypotensive effect of the conscious rabbit. (1974) (2)
Catecholamines in Exercise and Hyperventilation-Induced Asthma (1980) (2)
Proving New Drugs (1969) (2)
Specific quantitative determination of 6-oxo-prostaglandin F1 alpha in human plasma. (1983) (2)
Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine. (1989) (2)
A comparison of the cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. (1971) (2)
Impact of the new biology on research and teaching (1992) (2)
Current Developments in Ophthalmology (1964) (2)
Quantitative analysis of noradrenaline clearance [proceedings]. (1979) (2)
Regulation of norepinephrine release by peripheral alpha 2-receptor stimulation. (1981) (2)
Production of 6-oxo-PGF1 alpha by human lung in vivo. (1979) (2)
Resistance to beta-adrenoceptor stimulants and death from bronchial asthma. (1971) (2)
Changing pattern of death in hypertension. (1969) (2)
Classification of diabetic retinopathy. (1972) (2)
Local mediator release in bee venom anaphylaxis (1989) (2)
Detection of Unilateral Renal Disease in Hypertension with Diodrast 131I (1960) (2)
Increased Urinary Excretion of Leukotriene E4 in Decompensated Liver Disease (1988) (2)
The End of an Age of Optimism. Medical Science in Retrospect and Prospect (1979) (2)
Effects of Vasodilator Drugs on the Pulmonary Circulation (1970) (1)
Systemic candidiasis: an unusual complication of eating mutton. (1989) (1)
DISOPYRAMIDE IN MYOCARDIAL INFARCTION (1977) (1)
British gene therapy center. (1994) (1)
Treatment of malignant hypertension. (1966) (1)
The decision to treat: profiling benefit. (1985) (1)
Effect of Forearm Ischaemia and Aspirin on Circulating Prostacyclin in Man (1980) (1)
Heparin Kinetics inVenous Thrombosis andPulmonary Embolism (1975) (1)
Studies byfluorescence photography ofpapilloedema inmalignant hypertension (1965) (1)
Single-cell analysis: visualizing pharmaceutical and metabolite uptake in cells with label-free 3D mass. (2015) (1)
Hypertension (1942) (1)
Hypertension in the Elderly (1966) (1)
Clinical medicine and research in France. (1973) (1)
Deterioration in glucose tolerance following prolonged diuretic treatment for hypertension [proceedings]. (1975) (1)
Constructive Attack (1972) (1)
Microcirculatory changes and the cotton-wool spot. (1969) (1)
Fewer hospitals, bigger medical schools (1993) (1)
Why are Retinal Vessels Wider on Fluorescence Angiograms than on Colour Photographs?1 (1972) (1)
[Beta blockers and the central nervous system]. (1984) (1)
Regulation of Cardiac Output (1963) (1)
FOR COMBINATION THERAPY OF HYPERTENSION (1977) (1)
Drug infusion and monitoring of blood pressure by radio-telemetry in unrestrained pigs. (1970) (1)
Problems with measurement of icosanoids in biological fluids. (1985) (1)
Diseases of the heart and blood-vessels. Hypertension in the elderly. (1966) (1)
BYSSINOSIS AND ATMOSPHERIC POLLUTION. (1964) (1)
Double-blind, placebo controlled, cross-over comparison of the sedative and haemodynamic effect of single doses of clonidine and nitrazepam [proceedings]. (1979) (1)
Sustained Increase in Sympathetic Activity Due to Neuronal Uptake of Adrenaline: Mechanism for Stress-Induced Hypertension and Arrhythmias? (1982) (1)
The identity of IgE receptors (Fc epsilon RII) that mediate cellular activation of human macrophages: evidence against a role for CD23. (1992) (1)
Telemetry-controlled drug infusion and blood pressure monitoring in unrestrained pigs. (1969) (1)
UPTAKE OF OXYGEN-15-LABELED CO$sub 2$ COMPARED WITH CARBON-11-LABELED CO$sub 2$ IN THE LUNG (1962) (1)
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. (1980) (1)
An explanation for the exaggerated response of retinal blood vessels to oxygen. (1969) (1)
HYPERTENSIVE RETINOPATHY. (2020) (1)
Factors affecting the production of prostacyclin in man. (1981) (1)
Proceedings: Heparin kinetics in venous thrombosis and pulmonary embolism. (1975) (1)
The rate of formation and disapearance of microaneurysms i diabetic retinopathy. (1970) (1)
Chasing the lion's tail. The value of program review: a case study from the management of Leonotis nepetifolia (L.) R.Br. in Rinyirru (Lakefield) National Park. (2012) (1)
INTRACORONARY INFUSION OF VASOACTIVE PEPTIDES (1989) (1)
Absence of circulating PGI2 response to bubble-provoking decompression. (1987) (1)
Effect of Enalapril and Terfenadine on Intradermal Antigen Challenge (1987) (1)
Pharmaceutical medicine and academic clinical pharmacology: a convergent pathway? (2000) (1)
The possible role of circulating 6-oxo-PGF1 alpha in monitoring the growth and spread of malignant disease of the prostate. (1981) (1)
The retinal circulation in hypertension and diabetes. (1969) (1)
Effect ofenalapril ontheskin response tobradykinin inman (1987) (1)
Hypertension and new antihypertensive drugs: clinical perspectives. (1983) (1)
Desmethylimipramine and the hypotensive action of clonidine in the rabbit. (1973) (1)
Local histamine release after immunological and non-immunological mast cell degranulationin vivo (1984) (1)
Diagnosis of small phaeochromocytomas. (1980) (1)
Endogenous Circulating Catecholamines and Histamine in Asthmatic Subjects (1981) (1)
Hypotensive effects of diuretics. (1962) (0)
Session V. Regulatory differences and similarities; Drug regulation in the United Kingdom (1976) (0)
Registered Release: a Method for Detecting Adverse Drug Reactions (1979) (0)
Diuretic Treatment and Myocardial Infarction (1989) (0)
Regulation of adenylate cyclase by prostacyclin in a neuronal hybrid cell line [proceedings]. (1979) (0)
Importance of β2 Stimulation in the Suppression of Intradermal Antigen Challenge by Adrenaline (1987) (0)
Experimental hypertensive retinopathy: circulatory changes. (1971) (0)
Interventional cardiology and coronary artery disease (2010) (0)
Microvascular Permeability in Hypertension and its Response to Angiotensin Converting Enzyme (ACE) Blockade (1989) (0)
Effects ofpapaverine ontheretinal microcirculation (1973) (0)
Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings]. (1979) (0)
Book Review: Lidocaine in the Treatment of Ventricular Arrhythmias (1971) (0)
Contents, Vol. 35, 1959 (1959) (0)
Chairman's Introduction (1977) (0)
[Circulatory effect of chlorothiazide in hypertension]. (1959) (0)
Sickness and Society (1972) (0)
TREATMENT OF HYPERTENSION IN ELDERLY PATIENTS. AUTHORS' REPLY (1997) (0)
Book Review: Drugs and Sensory Functions (1968) (0)
Treatment of hypertension in elderly patients (1997) (0)
Drug regulation in the United Kingdom. (1976) (0)
ETHACRYNIC ACID. (2020) (0)
Propranolol (1972) (0)
Sub-aortic Stenosis (1965) (0)
Book Review: Proving New Drugs (1969) (0)
Register rerum ad Vol. XXXV (1959) (0)
Academic‐industrial relations in the United Kingdom (1985) (0)
PIATELETS AND VASCULAR OCCLUSION Therapeutic opportunities in vasoocclusive disease (2005) (0)
MEDICAL management of hypertension. (1963) (0)
Effect of Propranolol on Plasma Norepinephrine during Sodium Nitroprusside-Induced Hypotension (1981) (0)
Psychological features of patients with hypertension attending follow-up clinics. (1976) (0)
Discussion (1974) (0)
Initial care ofhypertensive patients Influence ofdifferent types ofclinical records (1977) (0)
Book reviewsPulmonary Investigation with Radionuclides. By GilsonA. J. and SmoakW. M., pp. xvii + 371 (illus.), 1970 (Charles C. Thomas, Springfield, Illinois),$21. 50. (1971) (0)
Summary of Discussions (1978) (0)
Book Review: The Release of Catecholamines from Adrenergic Neurons (1979) (0)
Medical Management of Hypertension (1963) (0)
Management of hypertension: risk-benefit ratio. (1984) (0)
and Originals Surgical Treatment of Emphysema (2007) (0)
The risk identified from clinical trials (1987) (0)
Beta-adrenoceptor blocking drugs in primary and secondary prevention of myocardial infarction. (1987) (0)
and Originals Comparison of Cardiorespiratory Effects of Isoprenaline and Salbutamol in Patients with Bronchial Asthma (2006) (0)
The Influence of Hospitalization and Placebo Therapy on Sympathetic Activity and Blood Pressure in Essential Hypertensive Patients (1979) (0)
In vivo disposition of prostaglandin D2 in man (1984) (0)
Production of 6-Keto PGF1αby Human LungIn Vivo (1980) (0)
Prostanoid Excretion in Nephrotoxic Serum Nephritis in the Rat (1989) (0)
Alpha-adrenoceptor binding in guinea-pig lung using [3H]-prazosin [proceedings]. (1980) (0)
E.C.G. Atlas (1963) (0)
The Effect of Smoking upon Ethylene Oxide Adduct Formation and Urinary 2,3-Dinor Thromboxane B2 Excretion (1988) (0)
Current Practice Polyarteritis Nodosa (2007) (0)
The effect of MAO inhibitors on pre-systemic deamination of tyramine in the dog intestine (1984) (0)
Production of leukotriene B4 by human pulmonary macrophages (1983) (0)
Interpretation of Fluorescein Dye Curves in the Retina (1971) (0)
Alveolar gasconcentrations offluorocarbons-I 1 and -12inman after useofpressurized aerosols (2011) (0)
Malignant hypertension in general practice. (1985) (0)
Plasma catecholamines and the acute effects of oral L-dopa in Parkinsonian patients [proceedings]. (1979) (0)
Epidemiology and Treatment of Raised Blood Presspre (1973) (0)
Cardiovascular Effects of Dobutamine and Isoprenaline in Post-Operative Cardiac Surgical Patients (1975) (0)
Decarboxylase Inhibitors and the Actions of α-Methyldopa in Man (1976) (0)
PLATELETS AND THROMBOSIS. (1964) (0)
HAEMODYNAMIC STUDIES WITH METHYLDOPA TABLE I RESTING SUPINE BLOOD PRESSURE AND CARDIAC OuTruT BEFORE AND AFTER TREATMENT WITH METHYLDOPA Blood pressure (0)
Concluding remarks (1977) (0)
The water and sodium diuretic actions of atrial natriuretic peptide are not mediated through the renal dopamine system. (1990) (0)
LUNG BLOOD FLOW (1961) (0)
European journals, societies, and meetings. Meetings. (1973) (0)
Side-effects of anti-hypertensive drugs. (1965) (0)
Letter: Sterility after vasectomy. (1973) (0)
Some problems of hypertension. (1966) (0)
Indomethacin does not alter the sodium excretion and the urinary dilution caused by human alpha atrial natriuretic peptide in man (1987) (0)
Effect ofchanges inintraocular pressure ontheretinal microcirculation (2011) (0)
Topics in Therapeutics 4 (1979) (0)
Advances in the treatment of hypertension. (1970) (0)
Assessment of Mediator Release in Allergic Rhinitis by Urinalysis (1989) (0)
Problems in clinical trials. (1967) (0)
Reversibility of Diuretic Induced Glucose Intolerance (1982) (0)
World conference on clinical pharmacology and therapeutics, London, August 3–9, 1980 (2004) (0)
Eighth annual meeting of the European Association for the Study of Diabetes (1973) (0)
Prevention of DOCA saline hypertension by central 6-hydroxydopamine: role of saline intake. (1975) (0)
LUNG BLOOD-FLOW IN MITRAL STENOSIS (1965) (0)
Useof18Flabelled fluorocarbon-i toinvestigate the fate ofinhaled fluorocarbons inman andintherat (2011) (0)
Chairman's Summary (2004) (0)
Optimism abounds (1994) (0)
Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man (2004) (0)
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]. (1979) (0)
The drug treatment of hypertension. (1971) (0)
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. (1969) (0)
coronary artery disease . patients with hypertension or serum lipids and lipoproteins in adrenoreceptor blockade on Effects of short term beta (0)
Letter: Computer-held medical records. (1976) (0)
Retinal blood flow studies (0)
The retinal circulation in health and disease. (1973) (0)
Effects of papaverine on the retinal microcirculation 9 I 1 Eye Preparation (2005) (0)
ATENOLOLANDCHLORTHALIDONE IN COMBINATIONFORHYPERTENSION (1979) (0)
Heparin Kinetics in venons Thrombosis and Pulmonary Embolism (1975) (0)
FLUORESCEINSTUDIESOF THE RETINAL CIRCULATIONINDIABETICS*t (1963) (0)
A NEW LIFE. (1964) (0)
Proceedings of the fourth Deer Lodge Conference on Clinical Pharmacology: Environmental chemicals and nutrition--relationship to metabolism, action, and toxicity of drugs: concluding remarks. (1977) (0)
The role of central and peripheral mechanisms in the maintenance of experimental hypertension in the rabbit. (1973) (0)
High Pressure Autoregulatory Failure in the Retinal Circulation (1979) (0)
Vision and Circulation (1976) (0)
Importance of central catecholaminergic neurones in renal hypertension in rabbits. (1972) (0)
o-Adrenoceptor binding in guinea-pig lung using [3H]-prazosin (2007) (0)
Cardiovascular effects of UK 14,275: evaluation of a new phosphodiesterase inhibitor with inotropic properties in animals and human volunteers [proceedings]. (1975) (0)
Proceedings: Computer-based hypertension clinic records: a collaborative study. (1973) (0)
How Much Regulation is Desirable in Clinical Practice (1983) (0)
Investigative Clinical Pharmacology (2011) (0)
Book Review: Vision and Circulation (1976) (0)
Circulatory Clinical and Pathological Aspects of the Cotton-wool Spots (1969) (0)
The assessment of efficacy, toxicity and quality of care in long-term drug treatment. (1976) (0)
Antipyrine induction and hepatic vitamin D hydroxylation in man [proceedings]. (1979) (0)
Welcome (1976) (0)
I. H. Stockley. Drug interactions. Blackwell Scientific Publications Ltd., Oxford, 1991; 679 pp., $39.50 (1992) (0)
British Gene Therapy Center (1994) (0)
Clinical Pharmacological Considerations in the Treatment of Hypertension in the Elderly (1989) (0)
Pulmonary adrenoceptors and asthma. (1983) (0)
The Management of Hypertension (1984) (0)
Session III. Clinical Aspects of Orthostatic Dysregulation (1976) (0)
New Drugs for the 1990's, the Challenge for the Clinical Pharmacologist. (1992) (0)
An academy of medicine: a future for British postgraduate medicine? (1995) (0)
Effects of Acetyleholine on Regional Pulmonary Blood Flow in Patients with Mitral Stenosis (2005) (0)
Effects ofIsoprenaline and Salbutamol inPatients withBronchial Asthma (1970) (0)
The Carcinoid Syndrome (1973) (0)
Renal Fuction and the Lupus Syndrome in Hydralazine Treated Hypertensive Patients (1988) (0)
Proceedings: Cardiovascular effects of dobutamine, a selective inotropic catecholamine. (1974) (0)
Metabolism of drugs in the isolated perfused dog lung (T) (1972) (0)
Methyldopa and Depression (1973) (0)
[HYPERTENSIVE RETINOPATHY]. (1965) (0)
Do human mast cells possess functional beta adrenoceptors in vivo? (1983) (0)
Antagonism of V2-receptor effect of antidiuretic hormone by atrial natriuretic peptide in man (1988) (0)
Increased α- and Reduced β-Adrenoreceptor Numbers in Experimental Asthma (1980) (0)
Vascular and platelet effects of prostacyclin and prostaglandin D 2 in man (1984) (0)
Session II. Physiopathology and Clinical Aspects of Cardiovascular Dysregulation, Especially Orthostatic (1976) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Colin Terence Dollery?

Colin Terence Dollery is affiliated with the following schools:

Colin Terence Dollery's Academic­Influence.com Rankings

Why Is Colin Terence Dollery Influential?

Colin Terence Dollery's Published Works

Published Works

What Schools Are Affiliated With Colin Terence Dollery?

Colin Terence Dollery's AcademicInfluence.com Rankings